The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231.
about
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivationDACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growthActivation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequencesHER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cellsCD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines.K-ras mutations in sinonasal cancers in relation to wood dust exposure.Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing.Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells.Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of functionEpidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells.GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.Ribosome-induced tuning of GTP hydrolysis by a translational GTPaseDeguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.Next-generation sequencing reveals the biological significance of the N(2),3-ethenoguanine lesion in vivoTargeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcriptionMispair formation in DNA can involve rare tautomeric forms in the template.Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators.Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer.Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues.The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cellsIgf1r as a therapeutic target in a mouse model of basal-like breast cancerBreast cancer metastasis suppressor-1 differentially modulates growth factor signaling.Integrated analysis of breast cancer cell lines reveals unique signaling pathways.Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathwayHonokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factorsThe EGF receptor system as a target for antitumor therapy.Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.The proto-oncogene KRAS is targeted by miR-200c.Evidence for aldosterone-dependent growth of renal cell carcinoma.Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation.A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells.The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.IGF-independent regulation of breast cancer growth by IGF binding proteins.
P2860
Q21195230-B576710F-5EB0-48A6-A666-B5B7E13EAACDQ24303568-E655C849-4F7D-4BC7-8036-3C79AA8F6137Q24564358-DF2B43F9-ADBD-416B-9707-2CEFDCF961CBQ25257668-4A91DF55-B6D9-4F3B-82B1-37750DE9ECA5Q30431290-399E2911-33A7-4947-9B3D-9D7BD9DB187AQ30575256-F481B90A-9DBC-4592-A7E8-EF5F72C08E6AQ33320695-F55D8B51-31EB-4CC8-AD1D-E54E86231267Q33549613-F4D6B321-C962-4A05-8DDD-21A1D2A23182Q33686865-875BD6AE-8F4B-43D9-BEBE-CAF0AE413FB3Q33823577-3283AA81-F2B7-427F-ACCA-5AC00249CFE3Q33825046-B9B465E7-4042-440F-8C92-60A4D47AF16AQ33893378-9B0A32A2-AB28-4071-8802-88878265AD0AQ34066386-BFE240FF-3FEB-4297-B830-D74C10A23EFCQ34087168-A49BF64E-CF06-4089-BCC1-B4EA19C9F037Q34352727-C9129DAF-23CF-4786-9BC3-CD5175E210AAQ34407524-E04C68CB-CCB8-495F-81B3-83527393D4D9Q34769614-54BA99C8-8E59-4FFB-950F-882EDD71DEF1Q35770590-22D8C714-FB25-4DAD-95F3-8475F39CA891Q35973719-59C7BEFB-222C-40D6-AA7C-74069181AB6DQ36070110-8A0A7600-63FE-48BD-8F34-EB3719220DB3Q36081804-F9D00435-BC7A-4F42-812E-F9BF0ABA01BDQ36482942-77339D6B-E566-4E5D-B530-E7A8066201D4Q36686648-D855D5AF-3790-4F76-B781-27B233FE39A6Q36766981-D4C0D7E7-6E49-440A-8C50-2857A9B53397Q37041619-FFC37C89-508E-45A2-B843-F2348D474B28Q37114859-344E22E6-C1C8-4F27-9137-D00B1E4479B3Q37141501-934221E1-2173-4082-90A8-0647321F6ADBQ37213805-9CB472E9-4F57-4AD2-980D-DC9CE7C85DFBQ37284069-9ECF57A6-F16F-40F5-A3E2-6D5F9AD17BB5Q37380664-59DAB956-BE92-4B3F-B9D8-B3E1CC5BBEF0Q37420053-7E4AD3D7-992A-4F41-9007-D645D979DB7CQ37427689-9F81EBEA-4BC1-4E59-B358-8C702D784643Q37446199-E179FFD0-493F-49C3-8A03-A3883FED1AE7Q37649657-7B14D6BD-D15A-4E4E-8A42-A333B74EC4F5Q38997782-91DF178F-5588-4B54-AA70-CF5B560C83EDQ39281631-FC9D5740-BFFE-455B-A3D3-F05F55135E89Q39979475-BAB16F82-E94A-461E-A109-5E5E984B1F2BQ40070223-93D654B4-CCC3-43B0-8EFD-058A6FEB7BCCQ40456230-6747329F-FB3C-48BB-BC6F-B2D3D3B6C3B4Q41727247-3CA6FCE9-F750-4781-A351-26FBCC0C5C3A
P2860
The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231.
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@ast
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@en
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@nl
type
label
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@ast
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@en
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@nl
prefLabel
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@ast
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@en
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@nl
P2093
P2860
P356
P1476
The human c-Kirsten ras gene i ...... carcinoma cell line MDA-MB231.
@en
P2093
Bogaard ME
P2860
P304
P356
10.1093/NAR/15.15.5963
P407
P577
1987-08-01T00:00:00Z